TORONTO, ON / ACCESSWIRE / June 12, 2018 / SQI Diagnostics Inc. (TSX-V: SQD; OTCQB: SQIDF), will be presenting at this year's MicroCap Conference on June 21st in Toronto, Canada.
"We are pleased to be presenting at this key conference," said Andrew Morris, CEO of SQI Diagnostics. "This conference gives us the opportunity to share with the investment community the significant commercial progress made in the past year with our diagnostic and pharma customers."
Please join us for our company presentation on June 21, 2018 at 2:00 pm.
ABOUT SQI DIAGNOSTICS
SQI Diagnostics is a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics. The Company's proprietary microarray tests and fully-automated systems are designed to simplify protein and antibody testing workflow, increase throughput, reduce costs and provide excellent data quality. For more information, please visit www.sqidiagnostics.com.
CONFERENCE OVERVIEW AND STRUCTURE
The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.
The MicroCap Conference will take place in Toronto at the Sheraton Centre Hotel on June 21st. Registration will begin on Thursday at 7:00 AM and will last until the evening. These days will be jam-packed with company presentations, 1-on-1 meetings, roundtables, expert panel discussions, and plenty of time to network with other investors over food and drinks.
REGISTRATION FOR INVESTORS
To request free registration, please go to our website (www.microcapconf.com), and click the "Registration" button
For our most updated list of companies, please go to our website (www.microcapconf.com/toronto)
News Compliments of ACCESSWIRE
FOR MORE INFORMATION
Please visit: www.microcapconf.com/toronto
Or, contact Ashley Allard at [email protected]
SQI INVESTOR RELATIONS CONTACT:
Chief Executive Officer
416.674.9500 ext. 229
VP Finance and Administration
416.674.9500 ext. 277
SOURCE: SQI Diagnostics Inc.